Scientists working on gene editing need to talk about the responsible use of such techniques, geneticist Jennifer Doudna said ina lecture on Monday. Doudna, one of the key players behind the discovery ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Victoria Gray, the first patient treated with CRISPR, and Jennifer Doudna, the CRISPR pioneer, at the 2025 Liberty Science Center's Genius Gala. In a recent conversation with Nobel Prize winning ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

In 2020, Jennifer Doudna, Ph.D., received the Nobel Prize in Chemistry, CRISPR-Cas9, a method for genome editing. Often referred to as “molecular scissors,” CRISPR cuts DNA at specific locations that ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

A new study in Nature Communications could influence how gene therapies are designed for many genetic diseases. Pictured: Gokul Ramadoss, the first author, is a PhD candidate in Bruce Conklin's lab at ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...